Location: Home
  • search
  • go
  • Relate News
  • 11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors
  • 11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma
  • 11/19/2018CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi
  • 11/19/2018CCDRC Approves Plan for National Centralized Drug Purchase Trial
  • 11/19/2018NH Reports on Chinese OTC Eye Care Market in MAT 09/2018
  • 11/19/2018Eli Lilly Mulls Sale of Certain Off-patent CNS and Antibiotic Assets i...
  • 11/16/2018NMPA Approves Gilead's Vemlidy (Tenofovir Alafenamide) in China
  • 11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...
  • 11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...
  • 11/15/2018How China Will Handle Its Trade War With the United States in 2019
  • 11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...
  • 11/15/2018Catalent Invests in Its 2nd Clinical Supply Facility in Shanghai
  • 11/15/2018President Xi Pledges to Protect IP and Boost Import at 1st Import Expo
  • 11/14/2018U.S. Trade Union Urges USFDA to Investigate GNC Acquisition by Harbin ...
  • 11/13/2018CFIUS Broadens Coverage of Cross-Border Biotech Transactions
  • 11/13/2018China's Crackdown on Genetics Breaches Could Deter Data Sharing
  • 11/13/2018NMPA Issues Rules for Drug Export Sales Certificate
  • 11/12/2018Angion Biomedica and Sinovant Enter Licensing Deal to Develop AKI Drug...
  • 11/12/2018Yifan Subsidiary Announces Chinese IND Approval of Anticaner A-319
  • 11/12/2018Innovent Files Chinese NDA for Humira Biosimilar IBI303
  • 11/12/2018In China, Desperate Patients Smuggle Drugs. Or Make Their Own.
  • 11/12/2018Merck to Quadruple Gardasil Supply in China to Meet Fast-rising Demand
  • 11/12/2018Leading MNCs Tout Renewed China Business Growth in Q3
  • 11/12/2018BeiGene Delays US Filing for BTK Inhibitor Zanubrutinib
  • 11/12/2018Eisai Launches HCC Drug LENVIMA (lenvatinib) in China
  • 11/12/2018SAMR Solicits Comments on Vaccine Administration Law
  • 11/12/2018SAMR Solicits Comments on Production Licensing Regulation for Formulat...
  • 11/12/2018Guangdong Introduces Implementation Plan for Generic Drug Supply and C...
  • 11/11/2018China Step Up Crackdown on Medical Frauds by Charities
  • 11/11/2018Merck KGaA Paves the Way for its Innovation Hub in Southern China
  • Page:248/720 Total number of articles:21572: [First][<<] [246] [247] [248] [249] [250] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group